BPC-157 and TB-500 side by side
Both are not officially tested in dogs and not FDA-approved for animals. This table shows the facts we could verify, and the gaps in the evidence are the main finding.
| What we checked | BPC-157 | TB-500 |
|---|---|---|
| What it is | A lab-made chain of amino acids, studied in the lab since the 1990s | A lab-made fragment based on part of thymosin beta-4, a protein the body makes |
| Sold for | Tendons, ligaments, joints, gut, recovery | Tendons, ligaments, joints, wounds, recovery |
| Clinical trials in dogs | None in PubMed (checked 6 Nov 2026) | None in PubMed (checked 6 Nov 2026) |
| Any dog data | Two lab papers in healthy research beagles | We found no study giving it to dogs |
| Tested in dogs with an injury or illness? | No | No |
| How it's sold for pets | Vials, capsules, oils, drops and treats, alone or in blends | Vials, drops and treats, often in blends with BPC-157 |
| FDA-approved for animals? | No | No |
| FDA safety concerns for human compounding | On FDA's list: possible immune reactions, impurities | On FDA's list: possible clumping and impurities, no exposure data |
| Safe amount for a pet dog | Unknown | Unknown |
| Long-term safety | Unknown | Unknown |
Same answer for bothUnknown nobody has studied it
What each one is
BPC-157 is a short chain of amino acids. FDA has said that products sold under that name can differ, because multiple salts and derivatives have been sold under the same common name. A vial labelled BPC-157 may not hold the same thing as another vial with that label.
TB-500 needs a careful reading of the marketing. FDA's list calls it a fragment of thymosin beta-4. Some pages quote research on full thymosin beta-4, which is a larger, natural protein. A result for the whole protein may not apply to a fragment.
What evidence exists in dogs
For BPC-157, two papers include dogs. Xu 2020 reported that healthy research beagles tolerated repeated doses in a toxicity study. He 2022 measured how quickly beagles clear it. Neither tested sick pets, long-term use or products owners can buy, and neither shows that it treats anything.
For TB-500, our PubMed search of TB-500 and thymosin beta-4 in dogs turned up nothing where either was given to a dog. In other words, BPC-157 has a thin record in dogs and TB-500 has none we could find. Having a little safety data does not make BPC-157 more useful. It has still never been shown to do anything for a dog's injury.
Why there is no winner
A fair comparison needs both things tested in the same kind of dog, with the same problem, against a placebo. No such study exists. Any page that ranks one above the other is working from theory or seller claims.
You may read that one suits the gut and tendons and the other suits wider tissue repair. Those ideas come from lab work and marketing, and they haven't been tested in dogs. Picking one because it sounds like a better match would be a guess.
A real comparison also needs products you can trust. Products aren't checked by FDA, so the label may not match what's inside, and a vial from one seller may have little in common with a vial from another.
What about blends?
Blends of the two are common in pet sellers' products. They are sold on the idea that the two work together, and that has not been tested in dogs. A blend means two unknowns in one vial. If your dog has a reaction, nobody can say which ingredient caused it, and the amount of each is hard to check. Our seller comparison shows which sellers publish lab reports, and how to check a lab report explains what those reports can and can't prove.
What your vet would look at instead
Owners usually compare these two because their dog has a specific problem. Vets start by finding out exactly what is wrong, then use treatments with real evidence behind them. See a vet for any limp lasting more than a day, any weakness in the legs, or gut trouble lasting more than a day or two.
| Problem | What vets usually do | Read more |
|---|---|---|
| Torn ACL | Surgery for most medium and large dogs, rehab | BPC-157 and ACL tears |
| Arthritis | Approved pain medicine, weight loss, rehab | Joint pain guide |
| Back pain or weakness | Urgent exam, rest or surgery | IVDD guide |
| Long-running gut trouble | Tests and a diet trial | Gut guide |
| Wounds | Cleaning, antibiotics if infected, stopping the licking | Wound guide |
What to ask your vet
Bring the product page or label to the visit. If you can't get in quickly, a licensed online vet can help you think it through. For the bigger picture, read are peptides safe for dogs?
- What exactly is wrong with my dog, and how sure are we?
- What are the tested treatments, and which comes first?
- Would this product clash with my dog's medicines or a planned surgery?
- If I went ahead anyway, what would you want to monitor?
Dutch and Vetster connect you with a vet by video or chat. Ask how urgent it is, and whether anything you have read about makes sense. Start a vet chat Paid link
Questions dog owners ask
Is BPC-157 or TB-500 better for dogs?
Neither can be called better. They have never been compared in dogs, neither has a clinical trial in dogs, and neither is FDA-approved for animals. Your dog's diagnosis and your vet's tested options matter far more than this choice.
Can dogs take BPC-157 and TB-500 together?
Nobody knows if it is safe. The blend has not been tested in dogs, and a blend makes a reaction harder to trace. Nothing shows that the two work better together. Talk to your vet before giving either.
Is TB-500 the same as thymosin beta-4?
No. FDA lists TB-500 as a fragment of thymosin beta-4. The full protein is larger and occurs naturally in the body, so research on it may not apply to a fragment sold in a vial.
Has TB-500 been studied in dogs?
We found no published study that gave TB-500 or thymosin beta-4 to dogs (PubMed, checked 6 Nov 2026). That means its safety in dogs is unknown. BPC-157 has two lab papers in healthy research beagles, which is little more.
Which is safer for my dog, BPC-157 or TB-500?
Nobody can say. A toxicity study reported that healthy research beagles tolerated BPC-157, and there is no similar paper for TB-500. Neither has been tested in sick pets or over the long term, and the products themselves aren't checked by FDA.
Sources
- PubMed, BPC-157 in dogs, clinical trials only: no results, checked 6 Nov 2026. Open
- PubMed, TB-500 and thymosin beta-4 in dogs, clinical trials only: no results, checked 6 Nov 2026. Open
- Xu C et al. Preclinical safety evaluation of body protective compound-157. Regul Toxicol Pharmacol, 2020. Open
- He L et al. Pharmacokinetics, distribution, metabolism and excretion of BPC157, including in beagle dogs. Front Pharmacol, 2022. Open
- FDA, Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (human compounding; page current as of 22 Apr 2026). Open
- FDA, Briefing Document, Pharmacy Compounding Advisory Committee, 23 to 24 Jul 2026 (BPC-157). Open
- FDA, Approved Animal Drug Products (Green Book): neither listed. Open